title: Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD).
abstract: BACKGROUND
  Acute exacerbations are a significant source of morbidity and mortality associated with chronic obstructive pulmonary disease. Among individuals with COPD, some patients suffer an inordinate number of exacerbations while others remain relatively protected. We undertook a study to determine the clinical factors associated with "frequent exacerbator" status within a population of subjects with severe COPD.
  
  
  METHODS
  Case-control cohort recruited from two Boston-area practices. All subjects had GOLD stage 3 or 4 (FEV(1) ≤ 50% predicted) COPD. "Frequent exacerbators" (n = 192) had an average of ≥2 moderate-to-severe exacerbations per year while "non-exacerbators" (n = 153) had no exacerbations in the preceding 12 months. Multivariate logistic regression was performed to determine the significant clinical predictors of "frequent exacerbator" status.
  
  
  RESULTS
  Physician-diagnosed asthma was a significant predictor of frequent exacerbations. Within a subset of our cohort, the modified Medical Research Council dyspnea score and FEF (25-75%) predicted were also significant clinical predictors of frequent exacerbator status (p < 0.05). Differences in exacerbation frequency were not found to be due to increased current tobacco use or decreased rates of maintenance medication use.
  
  
  CONCLUSIONS
  Within our severe COPD cohort, a history of physician-diagnosed asthma was found to be a significant clinical predictor of frequent exacerbations. Although traditional risk factors such as decreased FEV(1)% predicted were not significantly associated with frequent exacerbator status, lower mid-expiratory flow rates, as assessed by FEF (25-75%) predicted, were significantly associated with frequent exacerbations in a subset of our cohort.
authors.affiliation: Channing Laboratory, Boston, MA 02115, USA. emily.wan@channing.harvard.edu
authors.forename: Emily S
authors.initials: ES
authors.lastname: Wan
authors.forename: Dawn L
authors.initials: DL
authors.lastname: DeMeo
authors.forename: Craig P
authors.initials: CP
authors.lastname: Hersh
authors.forename: Steven D
authors.initials: SD
authors.lastname: Shapiro
authors.forename: Richard A
authors.initials: RA
authors.lastname: Rosiello
authors.forename: Susan R
authors.initials: SR
authors.lastname: Sama
authors.forename: Anne L
authors.initials: AL
authors.lastname: Fuhlbrigge
authors.forename: Marilyn G
authors.initials: MG
authors.lastname: Foreman
authors.forename: Edwin K
authors.initials: EK
authors.lastname: Silverman
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D018450:Disease Progression; D004417:Dyspnea / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D011788:Quality of Life / Q000523:psychology; D012129:Respiratory Function Tests; D012307:Risk Factors